Market Leadership HRA Pharma is a European leader in emergency contraception and compromised skin, with a growing pipeline including Rx-to-OTC switches. This positions them to expand self-care and over-the-counter products in regions with high demand for convenient, trust-backed solutions.

Expansion Footprint Headquartered in France with direct operations in 11 European countries and distribution partnerships extending to over 71 countries. This broad footprint opens channels for regional partnerships, co-marketing, and distribution deals to accelerate global reach.

Strategic Acquisitions Past and recent activity includes acquiring Merz’s assets and later Perrigo’s acquisition of HRA Pharma, signaling a willingness to pursue inorganic growth and integration opportunities that can create cross-sell opportunities for complementary brands.

Women’s Health Focus Strong emphasis on women’s health and self-care solutions, indicating potential cross-sell with consumer healthcare lines, telehealth partnerships, and educational campaigns to drive adoption of new OTC launches.

Tech & Compliance Adoption of modern web and security tech stacks (PWA, Proofpoint, jQuery) combined with regulatory and safety emphasis suggests suitability for collaboration on compliant digital marketing, patient support tools, and secure e-commerce initiatives for new products.